Brazilian researchers have developed a synthetic compound that has the potential to treat malaria and block its transmission. The new molecule acts during three phases of the disease cycle, ...

A new malaria vaccine achieves an unparalleled 89% efficacy by targeting late-liver-stage antigens, unlocking new horizons in the fight against global disease. Study: Safety and Efficacy of ...

Landmark findings from a major malaria clinical trial led by Menzies School of Health Research (Menzies) and international ...

Researchers studying the malaria parasite Plasmodium falciparum have discovered a previously unknown stage in its life cycle that appears to be crucial for reproduction. This is important because ...

Researchers studying the malaria parasite Plasmodium falciparum have discovered a previously unknown stage in its life cycle that appears to be crucial for reproduction. This is important because ...

Malaria is caused by a eukaryotic microbe of the Plasmodium genus, and is responsible for more deaths than all other parasitic diseases combined. In order to transmit from the human host to the ...

Malaria remains a key target for infectious disease prevention, particularly with resistance to common antimalarial drugs on the uptick. 1 However, a broadly effective vaccine for the deadly disease ...

Recognizing the future leaders of malaria research is fundamental to safeguarding tomorrow's driving force in innovation.This ...